Skip to main content
OpenTrials

Clinical trial condition

Synucleinopathies

Explore clinical trials studying Synucleinopathies. Study availability and eligibility vary by location and protocol.

3,503 public trials 645 recruiting studies
Refine in advanced search Browse all conditions

Synucleinopathies trial results

Completed

A Study of an Investigational Drug to See How it Affects the People With Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes) Compared to an Approved Drug Used to Treat People With Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes)

NCT03391882

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
Locations
  • Medical University Innsbruck, Neurolgy Dept Innsbruck, Austria
  • Wilhelminenspital, Department of Neurology Vienna, Austria
  • CHU Caremeau, Service de Neurologie Nîmes, France
  • Centre d'Investigation Clinique, CIC 43, CHU Purpan, Hopital Pierre-Paul Riquet, place du Dr. Baylac, Hall D, 2 eme etage -TSA Toulouse, France
View all 31 locations
View Trial Details
Completed

Exergames in In-patient Rehabilitation

NCT04872153

Conditions
Basal Ganglia Diseases, Brain Diseases, Cardiovascular Diseases, +9 more
Locations
  • Rehaklinik Dussnang Dussnang, Thurgau, Switzerland
  • Rehaklinik Zihlschlacht Zihlschlacht-Sitterdorf, Thurgau, Switzerland
View Trial Details
Completed

Open Label Continuation Treatment Study With Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's Disease

NCT00660673

Conditions
Advanced Parkinson's Disease, Basal Ganglia Diseases, Brain Diseases, +11 more
Locations
  • University of Alabama at Birmingham /ID# 49941 Birmingham, Alabama, United States
  • The Research Center of Southern California /ID# 49928 Encinitas, California, United States
  • The Parkinson's & Movement Disorder Institute - Fountain Valley /ID# 49915 Fountain Valley, California, United States
  • Universtiy of Southern California /ID# 49913 Los Angeles, California, United States
View all 61 locations
View Trial Details
Completed

Opicapone Treatment Initiation Open-Label Study

NCT04787965

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations
  • Neurocrine clinical site Los Gatos, California, United States
  • Neurocrine clinical site Memphis, Tennessee, United States
  • Neurocrine clinical site Christiansburg, Virginia, United States
  • Neurocrine clinical site Norfolk, Virginia, United States
View Trial Details

Related conditions